Invivogen
Menu

InvivoGen's product citations

Citations

InvivoGen’s products are frequently cited in peer-reviewed publications for a wide variety of applications and uses. Browse our product citations below.
Please note: By clicking on the product name, you can access via the ‘Citations’ tab all references of the product (click ‘load more’).

Citations search

You can search by ‘Product Name’ or ‘Year’.

Find a citation by product name
Enter a year of publication
Product Citation Year Journal Authors Page
Puromycin Deregulated JNK signaling enhances apoptosis during hyperthermia. 2024 Int J Hyperthermia Enomoto A. et al. DOI: 10.1080/02656736.2024.2335199
THP1-Dual™ Cells STING-Pathway Inhibiting Nanoparticles (SPINs) as a Platform for Treatment of... 2024 ACS Appl Bio Mater. Pastora L.E. et al. DOI: 10.1021/acsabm.3c01305
RAW-Dual™ Cells STING-Pathway Inhibiting Nanoparticles (SPINs) as a Platform for Treatment of... 2024 ACS Appl Bio Mater. Pastora L.E. et al. DOI: 10.1021/acsabm.3c01305
LumiKine™ Xpress mIFN-β 2.0 STING-Pathway Inhibiting Nanoparticles (SPINs) as a Platform for Treatment of... 2024 ACS Appl Bio Mater. Pastora L.E. et al. DOI: 10.1021/acsabm.3c01305
QUANTI-Luc™: Luciferase Detection Reagent STING-Pathway Inhibiting Nanoparticles (SPINs) as a Platform for Treatment of... 2024 ACS Appl Bio Mater. Pastora L.E. et al. DOI: 10.1021/acsabm.3c01305
THP1-Dual™ KO-TREX1 Cells STING-Pathway Inhibiting Nanoparticles (SPINs) as a Platform for Treatment of... 2024 ACS Appl Bio Mater. Pastora L.E. et al. DOI: 10.1021/acsabm.3c01305
Blasticidin miR-3188 inhibits hepatitis B virus transcription by targeting Bcl-2. 2024 Arch Virol. Wang S. et al. DOI: 10.1007/s00705-024-05992-x
HKCA Helper T cell immunity in humans with inherited CD4 deficiency. 2024 J Exp Med. Guérin A. et al. DOI: 10.1084/jem.20231044
LPS-SM Ultrapure (LPS from S. minnesota R595) A serine-conjugated butyrate prodrug with high oral bioavailability suppresse... 2024 Nat Biomed Eng. Cao S. et al. DOI: 10.1038/s41551-024-01190-x
Poly(I:C) HMW Characterization of feline-originated probiotics Lactobacillus rhamnosus CACC... 2024 BMC Vet Res. Jang H.J. et al. DOI: 10.1186/s12917-024-03975-3
Primocin® Influence of Substrate Stiffness on iPSC-Derived Retinal Pigmented Epithelial... 2024 Stem Cells Transl Med. Wendland R.J. et al. DOI: 10.1093/stcltm/szae022
Blasticidin Pathogenic effects of Leu200Pro and Arg387His VRK1 protein variants on phosph... 2024 J Mol Med (Berl). Campos-Díaz A. et al. DOI: 10.1007/s00109-024-02442-8
Puromycin Study on the Extrapolability of Current Tumorgenicity Test With Mice by Compa... 2024 Stem Cells Transl Med. Tamura T. et al. DOI: 10.1093/stcltm/szae019
Pam3CSK4 VacciGrade™ Metabolic trade-offs in Neonatal sepsis triggered by TLR4 and TLR1/2 ligands ... 2024 Brain Behav Immun. Joana Alves M. et al. DOI: 10.1016/j.bbi.2024.03.027
Puromycin DR30318, a novel tri-specific T cell engager for Claudin 18.2 positive cancer... 2024 Cancer Immunol Immunother. Ma Z. et al. DOI: 10.1007/s00262-024-03673-x
Puromycin Targeting the receptor tyrosine kinase MerTK shows therapeutic value in gastr... 2024 Cancer Med. Wirsik N.M. et al. DOI: 10.1002/cam4.6866
Recombinant anti-mouse CD20 antibody Mesenchymal stem cells alleviate mouse liver fibrosis by inhibiting pathogeni... 2024 Hepatology Feng X. et al. DOI: 10.1097/HEP.0000000000000831
Primocin® Protocol for generating mouse morula-like cells resembling 8- to 16-cell stag... 2024 STAR Protoc. Li H. et al. DOI: 10.1016/j.xpro.2024.102934
LPS-EK (LPS from E. coli K12) Clinical validation of circulating GDF15/MIC-1 as a marker of response to doc... 2024 Prostate Mahon K.L. et al. DOI: 10.1002/pros.24691
Alhydrogel® adjuvant 2% Immunogenicity and protective efficacy of inactivated coxsackievirus B4 viral... 2024 Emerg Microbes Infect. Wang T. et al. DOI: 10.1080/22221751.2024.2337665

Pages

Customer Service
& Technical Support
Contact us
Shopping cart is empty